Ajinomoto Bio-Pharma Services at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

Ajinomoto Bio-Pharma Services takes part in 1 session at TIDES Europe 2026 in Amsterdam, and exhibits at Booth 410. Its program centres on scaling oligonucleotide manufacturing beyond solid-phase synthesis. It sets out a CMC-guided move to AJIPHASE liquid-phase synthesis and to combined chemical and enzymatic siRNA production.

OrganizationTIDES Europe 2026 Attendance
ajibio-pharma.com
CDMO & CROBronze sponsor
Contract development and manufacturing organization for oligonucleotides, peptides and biologics, offering AJIPHASE liquid-phase synthesis technology.
Booth
Exhibiting at Booth 410
Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm
Talk
Wed Nov 4
13:25–13:55
Addressing the Next Scale of Oligonucleotide Manufacturing: CMC Guided Transition from Solid Phase Synthesis to AJIPHASE® and Chemical Enzymatic siRNA Production
Why one maker plans to move oligonucleotide production from solid-phase to liquid-phase chemistry, and how enzymes could join fragments at larger scale.
OligonucleotidesCMC & Manufacturing

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ajinomoto Bio-Pharma Services

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction